📈🌱 Exciting news for investors! 🙌🏼 Mutual funds are set to launch five new categories under the ESG scheme, as approved by SEBI. 🌟 This move will provide more options for socially responsible investing and promote sustainable development. 🌍 Stay tuned for updates on these new categories! 🌿📊
The Securities and Exchange Board of India (SEBI) has not announced any new guidelines related to the introduction of five new categories under the ESG (environmental, social, and governance) scheme for mutual funds. Please note that regulations and guidelines in the financial industry can change frequently, and it’s possible that new developments have occurred after […]
Read More
🚀 Exciting news! Concord Biotech, with the backing of Rakesh Jhunjhunwala’s firm, is targeting an IPO launch in August with a potential valuation of up to $1 billion. 🌟 We’re thrilled to be a part of this journey and can’t wait to see what the future holds for this innovative biotech company.
Concord Biotech, a leading biotechnology firm based in Ahmedabad, is preparing to launch its initial public offering (IPO) in early August. The company is backed by Rare Enterprises, the firm of the late veteran investor Rakesh Jhunjhunwala, and healthcare-focused Asian private equity firm Quadria Capital. The updated draft red herring prospectus (UDRHP) was filed with […]
Read More